Elaine, BS, MPAS, PA-C, will talk through whats actually going on with your body and whether weight loss medications make sense for you
The first GLP-1RA was approved by the FDA (U.S
Next, oral semaglutide 25 mg (Wegovy in a pill) is under regulatory review with strong phase 3 evidence, and orforglipron represents a newer smallmolecule oral GLP1 pathway with potential decisions in 2026
Even though you may be expecting them, it doesnt mean they cant be difficult to deal with
Nevertheless, significant shortcomings existed in such studies, including relatively short mean follow-up times (of less than 2 years in the RCTs), selected patient cohorts, and limited sample sizes
This new formulation achieves increase the ease of absorption by the body, so that its properties act more effectively